{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:15:49Z","timestamp":1794071749267,"version":"4.8.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006772","name":"Max and Minnie Tomerlin Voelcker Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.steroids.2024.109501","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T01:08:51Z","timestamp":1724807331000},"page":"109501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Structural perspectives on the androgen receptor, the elusive shape-shifter"],"prefix":"10.1016","volume":"211","author":[{"given":"Madisyn J.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2024.109501_b0005","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.steroids.2024.109501_b0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1110\/ps.051905906","article-title":"Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity","volume":"15","author":"Pereira de J\u00e9sus-Tran","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/2191155a0","article-title":"Metabolism of testosterone and action of metabolites on prostate glands grown in organ culture","volume":"219","author":"Baulieu","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2024.109501_b0025","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0021-9258(18)93542-8","article-title":"The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro","volume":"243","author":"Bruchovsky","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0030","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1038\/s41467-019-11594-y","article-title":"Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor","volume":"10","author":"Eftekharzadeh","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2024.109501_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.MCT-18-0432","article-title":"Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells","volume":"18","author":"Dong","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.steroids.2024.109501_b0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1242\/jcs.022103","article-title":"Structural basis for the nuclear import of the human androgen receptor","volume":"121","author":"Cutress","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13059-021-02339-6","article-title":"Functional mapping of androgen receptor enhancer activity","volume":"22","author":"Huang","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0050","article-title":"Canonical AREs are tumor suppressive regulatory elements in the prostate","author":"Augello","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.steroids.2024.109501_b0055","article-title":"Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription","author":"Lack","year":"2024","journal-title":"Res Sq."},{"key":"10.1016\/j.steroids.2024.109501_b0060","article-title":"NSD2 is a requisite subunit of the AR\/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis","author":"Parolia","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.steroids.2024.109501_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.steroids.2024.109501_b0070","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41589-022-01151-y","article-title":"Targeting androgen receptor phase separation to overcome antiandrogen resistance","volume":"18","author":"Xie","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0075","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41594-023-01159-5","article-title":"Rational optimization of a transcription factor activation domain inhibitor","volume":"30","author":"Basu","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0080","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.molcel.2023.08.027","article-title":"Hormone-induced enhancer assembly requires an optimal level of hormone receptor multivalent interactions","volume":"83","author":"Chen","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/nar\/gkac1158","article-title":"Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression","volume":"51","author":"Zhang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.steroids.2024.109501_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.str.2017.11.007","article-title":"Regulation of androgen receptor activity by transient interactions of its transactivation domain with general transcription regulators","volume":"26","author":"De Mol","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.steroids.2024.109501_b0095","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1074\/jbc.270.13.7341","article-title":"Identification of two transcription activation units in the N-terminal domain of the human androgen receptor","volume":"270","author":"Jenster","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/erc.0.0110281","article-title":"Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain","volume":"11","author":"McEwan","year":"2004","journal-title":"Endocr.-Relat Cancer"},{"key":"10.1016\/j.steroids.2024.109501_b0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1042\/bst0290222","article-title":"Structural and functional alterations in the androgen receptor in spinal bulbar muscular atrophy","volume":"29","author":"McEwan","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.steroids.2024.109501_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1677\/jme.0.0210235","article-title":"Trinucleotide repeats in the human androgen receptor: a molecular basis for disease","volume":"21","author":"Choong","year":"1998","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109501_b0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/PL00006391","article-title":"Evolution of the primate androgen receptor: a structural basis for disease","volume":"47","author":"Choong","year":"1998","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.steroids.2024.109501_b0120","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bpj.2016.04.022","article-title":"Sequence context influences the structure and aggregation behavior of a PolyQ Tract","volume":"110","author":"Eftekharzadeh","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.steroids.2024.109501_b0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2004.09.036","article-title":"Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance","volume":"16","author":"He","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0130","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1073\/pnas.0408819102","article-title":"The structural basis of androgen receptor activation: Intramolecular and intermolecular amino\u2013carboxy interactions","volume":"102","author":"Schaufele","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0135","first-page":"1970","article-title":"Stepwise androgen receptor dimerization","volume":"125","author":"van Royen","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0140","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1074\/jbc.M407046200","article-title":"The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor","volume":"280","author":"Est\u00e9banez-Perpi\u00f1\u00e1","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0145","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1371\/journal.pbio.0020274","article-title":"Recognition and accommodation at the androgen receptor coactivator binding interface","volume":"2","author":"Hur","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0150","doi-asserted-by":"crossref","first-page":"22986","DOI":"10.1074\/jbc.M002807200","article-title":"FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor","volume":"275","author":"He","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0155","doi-asserted-by":"crossref","first-page":"19407","DOI":"10.1074\/jbc.M602567200","article-title":"Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain","volume":"281","author":"van de Wijngaart","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0160","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1073\/pnas.1922159117","article-title":"Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG","volume":"117","author":"Wasmuth","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.steroids.2024.109501_b0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","article-title":"An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression","volume":"17","author":"Yu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.embor.7401046","article-title":"New androgen receptor genomic targets show an interaction with the ETS1 transcription factor","volume":"8","author":"Massie","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.steroids.2024.109501_b0175","doi-asserted-by":"crossref","first-page":"32611","DOI":"10.1038\/srep32611","article-title":"Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines","volume":"6","author":"Wilson","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.steroids.2024.109501_b0180","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1073\/pnas.0401123101","article-title":"Structural basis of androgen receptor binding to selective androgen response elements","volume":"101","author":"Shaffer","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106499","article-title":"Structural mechanism underlying variations in DNA binding by the androgen receptor","volume":"241","author":"Lee","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0190","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.molcel.2022.03.035","article-title":"Allosteric interactions prime androgen receptor dimerization and activation","volume":"82","author":"Wasmuth","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(12)60071-3","article-title":"Androgen insensitivity syndrome","volume":"380","author":"Hughes","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2024.109501_b0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.20945\/2359-3997000000031","article-title":"Androgen insensitivity syndrome: a review","volume":"62","author":"Batista","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109501_b0205","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/humu.22046","article-title":"The androgen receptor gene mutations database: 2012 update","volume":"33","author":"Gottlieb","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.steroids.2024.109501_b0210","first-page":"409","article-title":"Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance","volume":"6","author":"Zoppi","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109501_b0215","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/humu.9405","article-title":"Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome","volume":"27","author":"J\u00e4\u00e4skel\u00e4inen","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.steroids.2024.109501_b0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.0009-9163.2004.00197.x","article-title":"Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor","volume":"65","author":"Hooper","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.steroids.2024.109501_b0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0960-0760(93)90178-Y","article-title":"Mutations of androgen receptor gene in androgen insensitivity syndromes","volume":"46","author":"Sultan","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2024.109501_b0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(96)03812-9","article-title":"Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor","volume":"120","author":"Imasaki","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109501_b0235","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1210\/jc.2009-2146","article-title":"Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46, XY disorder of sex development","volume":"95","author":"Audi","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109501_b0240","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/hmg\/3.7.1169","article-title":"Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys\u2013>Phe substitution in the second zinc finger of the androgen receptor","volume":"3","author":"Baldazzl","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.steroids.2024.109501_b0245","first-page":"263","article-title":"Novel and recurrent mutations in patients with androgen insensitivity syndromes","volume":"63","author":"Ledig","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.steroids.2024.109501_b0250","doi-asserted-by":"crossref","first-page":"26164","DOI":"10.1074\/jbc.M004571200","article-title":"Structural evidence for ligand specificity in the binding domain of the human androgen receptor: implications for pathogenic gene mutations","volume":"275","author":"Matias","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0255","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.molonc.2014.06.009","article-title":"Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis","volume":"8","author":"Hsu","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.steroids.2024.109501_b0260","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1073\/pnas.0500381102","article-title":"Structural basis for antagonism and resistance of bicalutamide in prostate cancer","volume":"102","author":"Bohl","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109501_b0265","doi-asserted-by":"crossref","first-page":"37747","DOI":"10.1074\/jbc.M507464200","article-title":"Structural basis for accommodation of nonsteroidal ligands in the androgen receptor","volume":"280","author":"Bohl","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0270","doi-asserted-by":"crossref","first-page":"13648","DOI":"10.1074\/jbc.M611711200","article-title":"Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design","volume":"282","author":"Bohl","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1107\/S2053230X23002224","article-title":"A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations","volume":"79","author":"Doamekpor","year":"2023","journal-title":"Acta Crystallogr. Sect. F"},{"key":"10.1016\/j.steroids.2024.109501_b0280","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mce.2011.08.012","article-title":"A conserved surface on the ligand binding domain of nuclear receptors for allosteric control","volume":"348","author":"Buz\u00f3n","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109501_b0285","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1210\/me.2011-1281","article-title":"Allosteric conversation in the androgen receptor ligand-binding domain surfaces","volume":"26","author":"Grosdidier","year":"2012","journal-title":"Mol. Endocrinol. Baltim. Md"},{"key":"10.1016\/j.steroids.2024.109501_b0290","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1073\/pnas.0708036104","article-title":"A surface on the androgen receptor that allosterically regulates coactivator binding","volume":"104","author":"Est\u00e9banez-Perpi\u00f1\u00e1","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.steroids.2024.109501_b0295","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/jm011072j","article-title":"Structural basis for the glucocorticoid response in a mutant human androgen receptor (ARccr) derived from an androgen-independent prostate cancer","volume":"45","author":"Matias","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/jid.1966.86","volume":"46","author":"Neumann","year":"1966","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.steroids.2024.109501_b0305","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/415813a","article-title":"Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR\u03b1","volume":"415","author":"Xu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2024.109501_b0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0315","doi-asserted-by":"crossref","first-page":"e00499","DOI":"10.7554\/eLife.00499","article-title":"Overcoming mutation-based resistance to antiandrogens with rational drug design","volume":"2","author":"Balbas","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.steroids.2024.109501_b0320","doi-asserted-by":"crossref","first-page":"15887","DOI":"10.1038\/s41598-021-94707-2","article-title":"Conformational dynamics of androgen receptors bound to agonists and antagonists","volume":"11","author":"Gim","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.steroids.2024.109501_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182785","article-title":"Structure-based study to overcome cross-reactivity of novel androgen receptor inhibitors","volume":"11","author":"Radaeva","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.steroids.2024.109501_b0330","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2024.109501_b0335","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2024.109501_b0340","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.steroids.2024.109501_b0350","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.steroids.2024.109501_b0355","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2024.109501_b0360","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/jm2000097","article-title":"Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets","volume":"54","author":"Duke","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0365","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/jm300249m","article-title":"Discovery of diarylhydantoins as new selective androgen receptor modulators","volume":"55","author":"Nique","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0370","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.bmcl.2008.09.002","article-title":"Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators","volume":"18","author":"Bohl","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.steroids.2024.109501_b0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-020-3021-2","article-title":"A hydrophobic ratchet entrenches molecular complexes","volume":"588","author":"Hochberg","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2024.109501_b0380","doi-asserted-by":"crossref","first-page":"14388","DOI":"10.1038\/ncomms14388","article-title":"Structure of the homodimeric androgen receptor ligand-binding domain","volume":"8","author":"Nadal","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2024.109501_b0385","doi-asserted-by":"crossref","first-page":"eade2175","DOI":"10.1126\/sciadv.ade2175","article-title":"A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance","volume":"9","author":"Alegre-Mart\u00ed","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.steroids.2024.109501_b0390","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.molcel.2020.06.031","article-title":"Structural insights of transcriptionally active, full-length androgen receptor coactivator complexes","volume":"79","author":"Yu","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2024.109501_b0395","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.3216","article-title":"ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss","volume":"19","author":"Chen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2024.109501_b0400","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1535-7163.MCT-18-1386","article-title":"Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes","volume":"18","author":"Mao","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.steroids.2024.109501_b0405","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.steroids.2024.109501_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1998.8209","article-title":"Discovery of nonsteroidal androgens","volume":"244","author":"Dalton","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2024.109501_b0415","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/jm030336u","article-title":"Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators","volume":"47","author":"Marhefka","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0420","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1016\/S0021-9258(17)33103-4","article-title":"Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate","volume":"251","author":"Wilson","year":"1976","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109501_b0425","first-page":"8712","article-title":"Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer1","volume":"61","author":"Chang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2024.109501_b0430","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.105.088344","article-title":"The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators","volume":"315","author":"Kim","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T03:14:13Z","timestamp":1726024453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":86,"alternative-id":["S0039128X24001399"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109501","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural perspectives on the androgen receptor, the elusive shape-shifter","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109501"}}